Sugi Predict

Sugi Predict / Compounds / SCHEMBL789770

SCHEMBL789770

SCHEMBL789770

CC(=O)c1cccc(C(=O)OC(=O)c2cccc(C(C)=O)c2O)c1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.41
▸ KDM4E B2RXH2 3/20 0.40
▸ MAPT P10636 3/20 0.40
▸ THRB P10828 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ NSD2 O96028 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ MCL1 Q07820 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.39
▸ LMNA P02545 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ TSHR P16473 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ CA12 O43570 2/20 0.38
▸ CA1 P00915 2/20 0.38
▸ CA2 P00918 2/20 0.38
▸ CA7 P43166 2/20 0.38
▸ CA9 Q16790 2/20 0.38
▸ CA14 Q9ULX7 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10712239 0.88 KMT2A (0.41) KMT2AKDM4EMAPTTHRBMEN1
SCHEMBL7301332 0.87 THRB (0.50) KMT2AKDM4EMAPTTHRBMEN1
SCHEMBL2148841 0.86 LMNA (0.57) KMT2AKDM4EMAPTPOLBALDH1A1
SCHEMBL11420878 0.84 KMT2A (0.46) KMT2AKDM4EMAPTTHRBMEN1
SCHEMBL8587599 0.81 TSHR (0.44) KMT2AKDM4EPOLBALDH1A1HSD17B10
SCHEMBL8858805 0.81 KMT2A (0.37) KMT2AKDM4EMAPTTHRBMEN1
SCHEMBL4239107 0.81 TSHR (0.63) KMT2AMAPTMEN1POLBALDH1A1
SCHEMBL2174138 0.81 KDM4E (0.50) KMT2AKDM4EMAPTTHRBMEN1
SCHEMBL4221271 0.80 TSHR (0.43) KMT2AKDM4EMEN1POLBALDH1A1
SCHEMBL8850990 0.80 CYP3A4 (0.40) KMT2AKDM4EMAPTTHRBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118065203-B High-strength multi-pattern artificial turf and preparation method thereof 洛阳康迈斯人造草坪有限公司 2024-07-23 — — CN claimed
CN-118065203-A High-strength multi-pattern artificial turf and preparation method thereof 洛阳康迈斯人造草坪有限公司 2024-05-24 — — CN claimed
CN-113861096-B Indole structure-containing compound, preparation method and application thereof 中国农业大学 2023-07-18 — — CN claimed
CN-115448911-A Preparation method of posaconazole intermediate 成都海博为药业有限公司 2022-12-09 — — CN claimed
WO-2022228297-A1 ENZYMATIC PREPARATION TECHNIQUE FOR ACYL/AROYL COENZYME A 中国医学科学院药物研究所 2022-11-03 — — WO claimed
CN-115247192-A Enzymatic preparation technology of acyl/aroyl coenzyme A 中国医学科学院药物研究所 2022-10-28 — — CN claimed
CN-113861096-A Compound containing indole structure, preparation method and application thereof 中国农业大学 2021-12-31 — — CN claimed
CN-122042851-A Liquid chromatography method for determining aspirin content in calcium chloride-based cabapilin calcium mother liquor 山东青科农牧发展有限公司 2026-05-15 — — CN disclosed
CN-115448911-B Posaconazole intermediate Process for the preparation of intermediates 成都海博为药业有限公司 2024-08-16 — — CN disclosed
CN-118065203-B High-strength multi-pattern artificial turf and preparation method thereof 洛阳康迈斯人造草坪有限公司 2024-07-23 — — CN disclosed
CN-118065203-A High-strength multi-pattern artificial turf and preparation method thereof 洛阳康迈斯人造草坪有限公司 2024-05-24 — — CN disclosed
CN-111377816-B Compound for promoting myocardial regeneration, its preparation method, medicinal products and application 健裕生技股份有限公司 2023-10-20 — — CN disclosed
CN-113861096-B Indole structure-containing compound, preparation method and application thereof 中国农业大学 2023-07-18 — — CN disclosed
US-20020128523-A1 Process for the preparation of hydroxybenzoic benzyl esters LANXESS DEUTSCHLAND GMBH (DE) 2002-09-12 — — US disclosed
US-6306843-B1 SOLVENTS, SOLUTIONS AND MIXTURES OF DIMETHYLISOSORBIDE, PROPYLENE GLYCOL OR DIETHYLENE GLYCOL MONOETHYL ETHER, CYCLIC ACID IMIDE AND/OR SULFAMINIC ACID OF A COMPOUND OF AROMATIC ALCOHOL OR ETHER BURGHART WALTER (AT) 2001-10-23 — — US disclosed
US-5498729-A MIXED ANHYDRIDES DOMB ABRAHAM J (IL) 1996-03-12 — — US disclosed
EP-0510080-A4 PRODRUG ANHYDRIDES OF ASPRIN, INDOMETHACIN AND IBUPROFEN, THEIR PREPARATION, COMPOSITIONS, AND ANTI-INFLAMMATORY METHOD OF USE — 1992-12-02 — — EP disclosed
EP-0510080-A1 PRODRUG ANHYDRIDES OF ASPRIN, INDOMETHACIN AND IBUPROFEN, THEIR PREPARATION, COMPOSITIONS, AND ANTI-INFLAMMATORY METHOD OF USE NOVA PHARMACEUTICAL CORPORATION (US) 1992-10-28 — — EP disclosed
WO-1991009831-A1 PRODRUG ANHYDRIDES OF ASPRIN, INDOMETHACIN AND IBUPROFEN, THEIR PREPARATION, COMPOSITIONS, AND ANTI-INFLAMMATORY METHOD OF USE NOVA PHARMACEUTICAL CORPORATION (US) 1991-07-11 — — WO disclosed
US-4420482-A ANTITISTAMINES, ANALGESICS SELVI & C. S.P.A. (IT) 1983-12-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128523-A1 Process for the preparation of hydroxybenzoic benzyl esters HAAO, HPD, ALKBH3 KMT2A 513/4885KDM4E 202/4885MAPT 4172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.